alexa The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?


Journal of Pulmonary & Respiratory Medicine

Author(s): Gwilt CR, Donnelly LE, Rogers DF

Abstract Share this page

Abstract The parasympathetic neurotransmitter acetylcholine is also synthesised and secreted by non-neuronal cells and modifies their behaviour. This is termed the "non-neuronal cholinergic system" and is present in airway inflammatory cells. Acetylcholine is predominantly pro-inflammatory for lymphocytes and epithelial cells, anti-inflammatory for mast cells and macrophages, both pro- and anti-inflammatory for monocytes, and variable in neutrophils and eosinophils. Expression and function of components of the non-neuronal cholinergic system, for example cholinoceptors, can be modified by nicotine in cigarette smoke, the inflammation of asthma and chronic obstructive pulmonary disease (COPD), and the drugs used in clinical management of these diseases. The non-neuronal cholinergic system of airway inflammatory cells represents a previously unappreciated regulatory pathway, with immunomodulatory effects that potentially influence the inflammation of asthma and COPD. This article was published in Pharmacol Ther and referenced in Journal of Pulmonary & Respiratory Medicine

Relevant Expert PPTs

Relevant Speaker PPTs

  • Shoude Jin
    Mechanisms of Chronic obstructive pulmonary disease and airway smooth muscle remodeling: the potential roles of Abhd2
    PDF Version
  • Alsayed Alnahal
    Urinary netrin-1 predict early ischemic acute kidney injury after cardiopulmonary bypass
    PPT Version | PDF Version
  • Ping Yang
    Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
    PDF Version
  • Gunilla Lindqvist
    Chronic obstructive pulmonary disease: A study of the relationship between patients’ feeling of guilt due to their belief of the disease being self inflicted
    PDF Version
  • Roger Mark Engel
    The effect of including manual therapy in the management of mild chronic obstructive pulmonary disease – a randomized controlled trial
    PDF Version
  • Rupal Patel Mansukhani
    Correlation of Medication Therapy in Chronic Obstructive Pulmonary Disease(COPD) Patients with 30-day Readmission Rates
    PPT Version | PDF Version
  • Hadeel Faisal Gad
    In-vitro analysis of cytokines responses of visceral leishmaniasis and pulmonary tuberculosis patients to homologous and heterologous antigen stimulation
    PPT Version | PDF Version
  • Xin Wang
    IL17 Pathway Involves Moderating Pulmonary Hypertension, a common complication of COPD, in Statins Therapy in Smoking Rats
    PPT Version | PDF Version

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version